AKTX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Akari Therapeutics (AKTX) Earnings Date & Reports

Akari Therapeutics PLC is a clinical stage biopharmaceutical company... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

AKTX is expected to report earnings to rise 426.32% to -100 cents per share on September 27

Akari Therapeutics AKTX Stock Earnings Reports

Q2'23

Est.

$-1.00

Q4'24

Beat

by $0.81

Q1'23

Est.

$-0.06

Q4'22

Missed

by $0.08

Q3'22

Beat

by $0.02

The last earnings report on April 15 showed earnings per share of -18 cents, beating the estimate of -100 cents. With 2.47K shares outstanding, the current market capitalization sits at 41.29M.

View a ticker or compare two or three

Compare

AKTX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For AKTX
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

22 Boston Wharf Road

Phone

+1 929 274-7510

Employees

Web

https://www.akaritx.com